Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CPAC | CRH |
|---|---|---|
| Price | $12.13 | $81.06 |
| Change today | ▼ 0.74% | ▼ 0.49% |
| Market cap | $1.04B | $53.93B |
| Return, 3 months | +6.2% | -22.0% |
| Return, year to date | +16.4% | -34.3% |
| Return, 1 year | +66.9% | -30.2% |
| P/E (TTM) | 19.4 | 14.3 |
| P/B | 2.8 | 2.2 |
| P/E percentile vs own 5y | 92nd | 33rd |
| Dividend yield | 5.04% | 1.88% |
| Revenue growth (YoY, latest qtr) | +15.4% | +5.6% |
| Net profit growth (YoY) | +61.5% | +13.4% |
| Gross margin | 40.0% | 36.2% |
| Operating margin | 22.9% | 14.1% |
| Net margin | 9.5% | 9.9% |
| Return on equity | 16.0% | 16.4% |
| Analyst target vs. price | +7.2% | +66.1% |
| Analyst buy share | 0% | 100% |
| RSI (14) | 49 | 33 |
| 30-day volatility | 19.0% | 26.0% |
| Max drawdown, 1 year | -15.7% | -37.3% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Hold | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
